-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EKpi6gq/8Ux3JGmLks9Q5nqt3yyGL7ewTKglzq10s9KiEXB+9IOo6v4xdBjktLXl kBC5kcKmUvfdOdhyxF6O5Q== 0001193125-08-024253.txt : 20080208 0001193125-08-024253.hdr.sgml : 20080208 20080208154733 ACCESSION NUMBER: 0001193125-08-024253 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20080208 DATE AS OF CHANGE: 20080208 GROUP MEMBERS: ALTAS INSTITUTIONAL FUND, LTD. GROUP MEMBERS: ATLAS GLOBAL INVESTMENTS, LTD. GROUP MEMBERS: ATLAS GLOBAL, LLC GROUP MEMBERS: ATLAS MASTER FUND, LTD. GROUP MEMBERS: DMITRI BALYASNY SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BENTLEY PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000821616 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 591513162 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-40113 FILM NUMBER: 08589153 BUSINESS ADDRESS: STREET 1: BENTLEY PARK STREET 2: 2 HOLLAND WAY CITY: EXETER STATE: NH ZIP: 03833 BUSINESS PHONE: 6036586100 MAIL ADDRESS: STREET 1: BENTLEY PARK STREET 2: 2 HOLLAND WAY CITY: EXETER STATE: NH ZIP: 03833 FORMER COMPANY: FORMER CONFORMED NAME: BELMAC CORP /FL/ DATE OF NAME CHANGE: 19920703 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BALYASNY ASSET MANAGEMENT LLC CENTRAL INDEX KEY: 0001218710 IRS NUMBER: 364472709 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 181 W MADISON STE 3600 CITY: CHICAGO STATE: IL ZIP: 60602 BUSINESS PHONE: 3124992999 MAIL ADDRESS: STREET 1: 181 W MADISON STE 3600 CITY: CHICAGO STATE: IL ZIP: 60602 SC 13G/A 1 dsc13ga.htm AMENDMENT NO. 1 TO SCHEDULE 13G Amendment No. 1 to Schedule 13G

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13G

 

Under the Securities Exchange Act of 1934

(Amendment No. 1)

 

 

 

 

BENTLEY PHARMACEUTICALS, INC.

(Name of Issuer)

 

 

COMMON STOCK, Par Value $0.02 Per Share

(Title of Class of Securities)

 

 

082657107

(CUSIP Number)

 

 

December 31, 2007

(Date of Event Which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨ Rule 13d-1(b)

x Rule 13d-1(c)

¨ Rule 13d-1(d)

 

 

*   The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 082657107   Page 2 of 10 Pages

 

  1  

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (Entities Only)

 

            Atlas Master Fund, Ltd.

    
  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  ¨

(b)  ¨

    
  3  

SEC USE ONLY

 

    
  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

            Cayman Islands

    

 

NUMBER OF  

SHARES  

BENEFICIALLY  

OWNED BY  

EACH  

REPORTING  

PERSON  

WITH  

 

  

  5    SOLE VOTING POWER

 

                1,548,700 (See Item 4)

 

  6    SHARED VOTING POWER

 

                None

 

  7    SOLE DISPOSITIVE POWER

 

                1,548,700 (See Item 4)

 

  8    SHARED DISPOSITIVE POWER

 

                None

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

            1,548,700 (See Item 4)

    
10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

 

 

            Not Applicable

  

¨

 

11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

            6.93%

    
12  

TYPE OF REPORTING PERSON*

 

            CO

    

*SEE INSTRUCTIONS BEFORE FILLING OUT.

CUSIP No. 082657107   Page 3 of 10 Pages

 

  1  

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (Entities Only)

 

            Atlas Global, LLC

    
  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  ¨

(b)  ¨

    
  3  

SEC USE ONLY

 

    
  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

            Delaware

    

 

NUMBER OF  

SHARES  

BENEFICIALLY  

OWNED BY  

EACH  

REPORTING  

PERSON  

WITH  

 

  

  5    SOLE VOTING POWER

 

                None

 

  6    SHARED VOTING POWER

 

                1,548,700 (See Item 4)

 

  7    SOLE DISPOSITIVE POWER

 

                None

 

  8    SHARED DISPOSITIVE POWER

 

                1,548,700 (See Item 4)

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

            1,548,700 (See Item 4)

    
10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

 

 

            Not Applicable

  

¨

 

11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

            6.93%

    
12  

TYPE OF REPORTING PERSON*

 

            OO

    

*SEE INSTRUCTIONS BEFORE FILLING OUT.

CUSIP No. 082657107   Page 4 of 10 Pages

 

  1  

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (Entities Only)

 

            Atlas Global Investments, Ltd.

    
  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  ¨

(b)  ¨

    
  3  

SEC USE ONLY

 

    
  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

            Cayman Islands

    

 

NUMBER OF  

SHARES  

BENEFICIALLY  

OWNED BY  

EACH  

REPORTING  

PERSON  

WITH  

 

  

  5    SOLE VOTING POWER

 

                None

 

  6    SHARED VOTING POWER

 

                1,548,700 (See Item 4)

 

  7    SOLE DISPOSITIVE POWER

 

                None

 

  8    SHARED DISPOSITIVE POWER

 

                1,548,700 (See Item 4)

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

            1,548,700 (See Item 4)

    
10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

 

 

            Not Applicable

  

¨

 

11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

            6.93%

    
12  

TYPE OF REPORTING PERSON*

 

            CO

    

*SEE INSTRUCTIONS BEFORE FILLING OUT.

CUSIP No. 082657107   Page 5 of 10 Pages

 

  1  

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (Entities Only)

 

            Atlas Institutional Fund, Ltd.

    
  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  ¨

(b)  ¨

    
  3  

SEC USE ONLY

 

    
  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

            Cayman Islands

    

 

NUMBER OF  

SHARES  

BENEFICIALLY  

OWNED BY  

EACH  

REPORTING  

PERSON  

WITH  

 

  

  5    SOLE VOTING POWER

 

                None

 

  6    SHARED VOTING POWER

 

                1,548,700 (See Item 4)

 

  7    SOLE DISPOSITIVE POWER

 

                None

 

  8    SHARED DISPOSITIVE POWER

 

                1,548,700 (See Item 4)

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

            1,548,700 (See Item 4)

    
10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

 

 

            Not Applicable

  

¨

 

11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

            6.93%

    
12  

TYPE OF REPORTING PERSON*

 

            CO

    

*SEE INSTRUCTIONS BEFORE FILLING OUT.

CUSIP No. 082657107   Page 6 of 10 Pages

 

  1  

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (Entities Only)

 

            Balyasny Asset Management L.P.

    
  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  ¨

(b)  ¨

    
  3  

SEC USE ONLY

 

    
  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

            Delaware

    

 

NUMBER OF  

SHARES  

BENEFICIALLY  

OWNED BY  

EACH  

REPORTING  

PERSON  

WITH  

 

  

  5    SOLE VOTING POWER

 

                1,548,700 (See Item 4)

 

  6    SHARED VOTING POWER

 

                None

 

  7    SOLE DISPOSITIVE POWER

 

                1,548,700 (See Item 4)

 

  8    SHARED DISPOSITIVE POWER

 

                None

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

            1,548,700 (See Item 4)

    
10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

 

 

            Not Applicable

  

¨

 

11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

            6.93%

    
12  

TYPE OF REPORTING PERSON*

 

            OO

    

*SEE INSTRUCTIONS BEFORE FILLING OUT.

CUSIP No. 082657107   Page 7 of 10 Pages

 

  1  

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (Entities Only)

 

            Dmitry Balyasny

    
  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  ¨

(b)  ¨

    
  3  

SEC USE ONLY

 

    
  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

            United States

    

 

NUMBER OF  

SHARES  

BENEFICIALLY  

OWNED BY  

EACH  

REPORTING  

PERSON  

WITH  

 

  

  5    SOLE VOTING POWER

 

                1,548,700 (See Item 4)

 

  6    SHARED VOTING POWER

 

                None

 

  7    SOLE DISPOSITIVE POWER

 

                1,548,700 (See Item 4)

 

  8    SHARED DISPOSITIVE POWER

 

                None

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

            1,548,700 (See Item 4)

    
10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

 

 

            Not Applicable

  

¨

 

11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

            6.93%

    
12  

TYPE OF REPORTING PERSON*

 

            IN

    

*SEE INSTRUCTIONS BEFORE FILLING OUT.

Item 1  

(a)

    Name of Issuer:      
     Bentley Pharmaceuticals, Inc. (the “Company”)      
 

(b)

    Address of Issuer’s Principal Executive Offices:      
    

Bentley Park

Two Holland Way

Exeter, NH 03833

      
Item 2  

(a) – (c)

    This statement is filed on behalf of the following:      
     (1) Atlas Master Fund, Ltd., a Cayman Islands corporation (“AMF”), with its principal business office at c/o Walkers SPV Limited, Walker House, P.O. Box 908 GT, George Town, Grand Cayman, Cayman Islands, British West Indies.      
     (2) Atlas Global, LLC, a Delaware limited liability company (“AG”), with its principal business office at 181 West Madison, Suite 3600, Chicago, IL 60602. AG owns 9.00% of the equity interests in AMF.      
     (3) Atlas Global Investments, Ltd., a Cayman Islands corporation (“AGI”), with its principal business office at c/o Walkers SPV Limited, Walker House, P.O. Box 908 GT, George Town, Grand Cayman, Cayman Islands, British West Indies. AGI1 owns 90.00% of the equity interests in AMF.      
     (4) Atlas Institutional Fund, Ltd., a Cayman Islands corporation (“AIF”), with its principal business office at c/o Walkers SPV Limited, Walker House, P.O. Box 908 GT, George Town, Grand Cayman, Cayman Islands, British West Indies. AIF owns 1.00% of the equity interests in AMF.      
     (5) Balyasny Asset Management L.P., a Delaware limited partnership (“BAM”), with its principal business office at 181 West Madison, Suite 3600, Chicago, IL 60602. BAM is the sole managing member of AG and is the investment manager to each of AG and AGI.      
     (6) Dmitry Balyasny, a United States citizen whose business address is 181 West Madison, Suite 3600, Chicago, IL 60602. Dmitry Balyasny is the sole managing member of the general partner of BAM.      
 

(d)

    Title of Class of Securities:      
     Common Stock, Par Value $0.02 Per Share      
 

(e)

    CUSIP Number:      
     082657107      
Item 3   If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:   
  Not Applicable   

 

Page 8 of 10 Pages

Item 4    Ownership:      
   AMF      
   (a)    Amount Beneficially Owned:      
      1,548,700 shares      
   (b)    Percent of Class:      
      6.93%      
   (c)    Number of Shares as to which person has:      
      (i)    sole power to vote or to direct vote:      
         1,548,700 shares      
      (ii)    shared power to vote or to direct vote:      
         None      
      (iii)    sole power to dispose or direct disposition of:      
         1,548,700 shares      
      (iv)    shared power to dispose or to direct disposition of:      
         None      
   AG      
   (a)    Amount Beneficially Owned:      
      By virtue of its ownership of 9.00% of the equity interest in AMF, AG may be deemed to beneficially own the 1,548,700 shares of the Company’s Common Stock beneficially owned by AMF.      
   (b)    Percent of Class:      
      6.93%      
   (c)    Number of Shares as to which person has:      
      (i)    sole power to vote or to direct vote:      
         None      
      (ii)    shared power to vote or to direct vote:      
         1,548,700 shares      
      (iii)    sole power to dispose or direct disposition of:      
         None      
      (iv)    shared power to dispose or to direct disposition of:      
         1,548,700 shares      
   AGI      
   (a)    Amount Beneficially Owned:      
      By virtue of its ownership of 90.00% of the equity interest in AMF, AGI may be deemed to beneficially own the 1,548,700 shares of the Company’s Common Stock beneficially owned by AMF.      
   (b)    Percent of Class:      
      6.93%      
   (c)    Number of Shares as to which person has:      
      (i)    sole power to vote or to direct vote:      
         None      
      (ii)    shared power to vote or to direct vote:      
         1,548,700 shares      
      (iii)    sole power to dispose or direct disposition of:      
         None      
      (iv)    shared power to dispose or to direct disposition of:      
         1,548,700 shares      
   AIF      
   (a)    Amount Beneficially Owned:      
      By virtue of its ownership of 1.00% of the equity interest in AMF, AIF may be deemed to beneficially own the 1,548,700 shares of the Company’s Common Stock beneficially owned by AMF.      
   (b)    Percent of Class:      
      6.93%      
   (c)    Number of Shares as to which person has:      
      (i)    sole power to vote or to direct vote:      
         None      
      (ii)    shared power to vote or to direct vote:      
         1,548,700 shares      
      (iii)    sole power to dispose or direct disposition of:      
         None      
      (iv)    shared power to dispose or to direct disposition of:      
         1,548,700 shares      
   BAM      
   (a)    Amount Beneficially Owned:      
      By virtue of its position as investment manager of each of AG, AGI and AIF and its role as sole managing member of AG, BAM may be deemed to beneficially own the 1,548,700 shares of the Company’s Common Stock beneficially owned by AG and AGI.      
   (b)    Percent of Class:      
      6.93%      
   (c)    Number of Shares as to which person has:      
      (i)    sole power to vote or to direct vote:      
         1,548,700 shares      
      (ii)    shared power to vote or to direct vote:      
         None      
      (iii)    sole power to dispose or direct disposition of:      
         1,548,700 shares      
      (iv)    shared power to dispose or to direct disposition of:      
         None      
   Dmitry Balyasny      
   (a)    Amount Beneficially Owned:      
      By virtue of his position as the sole managing member of the general partner of BAM, Mr. Balyasny may be deemed to beneficially own the 1,548,700 shares of the Company’s Common Stock beneficially owned by BAM.      
   (b)    Percent of Class:      
      6.93%      
   (c)    Number of Shares as to which person has:      
      (i)    sole power to vote or to direct vote:      
         1,548,700 shares      
      (ii)    shared power to vote or to direct vote:      
         None      
      (iii)    sole power to dispose or direct disposition of:      
         1,548,700 shares      
      (iv)    shared power to dispose or to direct disposition of:      
         None      
Item 5    Ownership of Five Percent or Less of a Class:   
   [Not Applicable]   
Item 6    Ownership of More than Five Percent on Behalf of Another Person:      
   Not Applicable      
Item 7    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company:
   Not Applicable
Item 8    Identification and Classification of Members of the Group:      
   Not Applicable      
Item 9    Notice of Dissolution of Group:      
   Not Applicable      
Item 10    Certification:      
   By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.      

 

Page 9 of 10 Pages

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: February 7, 2008.

 

ATLAS MASTER FUND, LTD.     ATLAS INSTITUTIONAL FUND, LTD.
By:  

/s/ Scott Schroeder

     By:  

/s/ Scott Schroeder

  Scott Schroeder       Scott Schroeder
  Authorized Signatory       Authorized Signatory
ATLAS GLOBAL, LLC     BALYASNY ASSET MANAGEMENT L.P.
By:  

/s/ Scott Schroeder

     By:  

/s/ Scott Schroeder

  Scott Schroeder       Scott Schroeder
  Authorized Signatory       Authorized Signatory
ATLAS GLOBAL INVESTMENTS, LTD.     DMITRY BALYASNY
By:  

/s/ Scott Schroeder

     By:  

/s/ Scott Schroeder

  Scott Schroeder       Scott Schroeder
  Authorized Signatory       Authorized Representative and Executive Officer

 

Page 10 of 10 Pages

-----END PRIVACY-ENHANCED MESSAGE-----